A Safety Study of TTP4000 in Subjects With Alzheimer's Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The purpose of the study is to examine the safety, tolerability, immunogenicity and pharmacokinetics of TTP4000 in subjects with Alzheimer\'s disease with mild cognitive impairment.
Epistemonikos ID: 6a456595c386b8f2a68519d6101dbe6fde45c7df
First added on: May 10, 2024